finance
JPMorgan Downgrades Clorox Rating to Underweight from Neutral
JPMorgan has lowered its rating on The Clorox Company to Underweight from Neutral. The downgrade cites weak category growth, threats from private-label products, and rising costs for diesel and resin. Analysts noted that Clorox management has performed well in digital transformation and innovation but highlighted concerns over below-trend growth.
Apr 17, 6:46 AM·1m read1 source
Substrate placeholder — needs reviewAudio version
Tap play to generate a narrated version.
JPMorgan has downgraded its rating on The Clorox Company, listed as CLX on the NYSE, to Underweight from Neutral. The change reflects concerns about weak growth in product categories, competition from private-label brands, and increasing costs for diesel and resin.
JPMorgan analysts stated that Clorox management has effectively executed digital transformation initiatives and accelerated innovation efforts.
However, they warned of category growth trends falling below expectations, which could pressure earnings.
The downgrade occurs amid broader market conditions affecting consumer goods companies, including cost inflation and competitive pressures.
No specific timeline for potential recovery was provided in the assessment.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
